Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.01 EUR | -0.82% | +0.92% | +20.44% |
Apr. 25 | Price spiral in car insurance - 20 percent more expensive | DP |
Apr. 24 | Generali approves new EUR500 million buyback plan | AN |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- With a P/E ratio at 9.62 for the current year and 8.92 for next year, earnings multiples are highly attractive compared with competitors.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+20.44% | 38.53B | B | ||
+6.58% | 75.02B | B- | ||
+6.64% | 50.09B | B+ | ||
+0.85% | 48.36B | B | ||
+12.23% | 42.61B | B+ | ||
+8.25% | 39.96B | B+ | ||
+4.41% | 30.27B | B | ||
-3.72% | 28.4B | B- | ||
-14.77% | 24.95B | A- | ||
+9.73% | 22.74B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- G Stock
- Ratings Generali